Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

General Counsel

Chief Financial Officer

Chief Executive Officer

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-301 for the treatment of high-grade non-muscle invasive bladder cancer. Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for NMIBC. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and ur...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-18	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-02-01	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-02-01	Premium	sold	Premium	Premium	Premium	General Counsel
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	General Counsel
2024-01-31	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-31	Premium	sold	Premium	Premium	Premium	General Counsel
2023-08-31	Premium	sold	Premium	Premium	Premium	General Counsel
2023-08-31	Premium	acquired	Premium	Premium	Premium	General Counsel
2023-07-26	Premium	acquired	Premium	Premium	Premium	-
2023-01-31	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-01-31	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-01-31	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-01-31	Premium	sold	Premium	Premium	Premium	General Counsel
2023-01-31	Premium	acquired	Premium	Premium	Premium	General Counsel
2023-01-20	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2022-10-31	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2022-10-31	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2022-10-21	Premium	acquired	Premium	Premium	Premium	-
2022-09-14	Premium	acquired	Premium	Premium	Premium	-
2022-08-31	Premium	acquired	Premium	Premium	Premium	General Counsel
2022-08-31	Premium	sold	Premium	Premium	Premium	General Counsel

URGN - UroGen Pharma Ltd Stock Price, Fair Value and News

Latest Insider Trading transactions for URGN